Results 41 to 50 of about 1,765 (123)

Piperine suppresses M1 phenotype and induces indoleamine 2,3-dioxygenase gene in LPS-stimulated murine macrophage cell line. [PDF]

BMC Res Notes
Gholijani N, Dehghan Z, Abolmaali SS, Talepoor AG, Kalantar K, Daryabor G.   +5 more
europepmc   +1 more source

Advances in the restoration of CFTR in children and pwCF with "mild disease". [PDF]

Pediatr Pulmonol
Cohen-Cymberknoh M.
europepmc   +1 more source

Enantioselective radical chemistry: a bright future ahead. [PDF]

Beilstein J Org Chem
Renner AC, Thorat SS, Subramanian H, Sibi MP.   +3 more
europepmc   +1 more source

Home-based sleep monitoring using a novel non-contact, radar-based biomotion sensor in adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor. [PDF]

Sleep Breath
Dietz-Terjung S, Straßburg S, Schöbel C, Schulte T, Dietz P, Gahbiche FE, Ortiz J, Taube C, Weinreich G, Sutharsan S, Welsner M.   +10 more
europepmc   +1 more source

Impact of elexacaftor/tezacaftor/ivacaftor on the small airways in cystic fibrosis. [PDF]

J Bras Pneumol
Silva SC, Barroso A, Cunha M, Fragoso E, Azevedo P.   +4 more
europepmc   +1 more source

Assessment of efficacy and tolerability of elexacaftor-tezacaftor-ivacaftor in an observational cohort study of "aged" people with cystic fibrosis. [PDF]

Ther Adv Respir Dis
Blankenship S, Flueckiger BV, Caleb G, Bailey J, Baker E, Garcia B, Krick S.   +6 more
europepmc   +1 more source

Impact of Elexacaftor-Tezacaftor-Ivacaftor on Gastrointestinal Symptoms, Intestinal Ultrasound, and Pancreatic Stiffness in Cystic Fibrosis. [PDF]

Clin Transl Gastroenterol
Fraquelli M, Piagnani A, Corti F, Lanfranchi C, Casazza G, Colombo C.   +5 more
europepmc   +1 more source

Evaluation of Elexacaftor/Tezacaftor/Ivacaftor-Mediated Drug-Induced Liver Injury Using a Liver-On-Chip Model. [PDF]

Clin Transl Sci
Shi A, Agarwal P, Liu ZX, Beringer PM.
europepmc   +1 more source

Target-Guided Design and Synthesis of Aryl-Functionalized Promysalin Analogs. [PDF]

Chembiochem
Golden MM, Brzezinski CU, Wuest WM.
europepmc   +1 more source

Expanding the Impact of New Cystic Fibrosis Therapies in Low- and Middle-Income Countries. [PDF]

Pediatr Pulmonol
Kerem E.
europepmc   +1 more source